Cargando…
Future Perspectives on Drug Targeting in Adult T Cell Leukemia-Lymphoma
Human T cell leukemia virus type 1 (HTLV-1) is the etiological agent of adult T cell leukemia/lymphoma (ATL), HTLV-1 associated myelopathy (HAM/TSP), and of a number of inflammatory diseases with an estimated 10–20 million infected individuals worldwide. Despite a number of therapeutic approaches, a...
Autores principales: | Marino-Merlo, Francesca, Mastino, Antonio, Grelli, Sandro, Hermine, Olivier, Bazarbachi, Ali, Macchi, Beatrice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954109/ https://www.ncbi.nlm.nih.gov/pubmed/29867836 http://dx.doi.org/10.3389/fmicb.2018.00925 |
Ejemplares similares
-
Human T-Cell Leukemia Virus Type 1 Oncogenesis between Active Expression and Latency: A Possible Source for the Development of Therapeutic Targets
por: Marino-Merlo, Francesca, et al.
Publicado: (2023) -
Antiretroviral Therapy in HTLV-1 Infection: An Updated Overview
por: Marino-Merlo, Francesca, et al.
Publicado: (2020) -
Quantitative Evaluation of Very Low Levels of HIV-1 Reverse Transcriptase by a Novel Highly Sensitive RT-qPCR Assay
por: Marino-Merlo, Francesca, et al.
Publicado: (2022) -
Novel Treatments of Adult T Cell Leukemia Lymphoma
por: El Hajj, Hiba, et al.
Publicado: (2020) -
Inhibition of IκBα phosphorylation potentiates regulated cell death induced by azidothymidine in HTLV-1 infected cells
por: Matteucci, Claudia, et al.
Publicado: (2020)